YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. Food and Drug Administration yesterday approved the first new depression medication since the 1980s.
Johnson & Johnson's new drug Spravato is the brand name for esketamine, a nasal spray designed to treat severe forms of depression.
It contains the chemical mirror image of ketamine, which is used for its psychedelic effects.
Read more from Business Insider.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach